MarketPeel
Insider Trading Intelligence
DS

David Schaffer

FDMT
DIRECTOR · 4D MOLECULAR THERAPEUTICS, INC. · CIK 0001692929
FILING MIX · LIFETIME12%/88%
BUYS
2
SELLS
15
TOTAL VALUE
$3.06M
COMPANIES
2
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
904,835
AVG SELL PX
$30.77
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by David Schaffer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+92.86%-11.49%-0.12%-11.37%-11.34%
14d14+78.57%-11.62%+0.92%-12.54%-14.39%
30d14+85.71%-11.71%+3.67%-15.38%-17.92%
60d14+100.00%-28.14%+3.01%-31.15%-33.24%
90d14+92.86%-29.38%+6.26%-35.65%-38.67%
180d14+100.00%-48.71%+3.49%-52.20%-55.09%
1y14+100.00%-70.70%-13.35%-57.35%-57.28%
2y14+100.00%-60.09%+2.50%-62.59%-58.84%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FDMT · 901,215 shares · as of Oct 22, 2021
0246,731493,463740,194986,925SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
FLOW · 2 buys / 15 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
1,900$31.00$58.9K901,215Oct 22, 2021Oct 22, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
22,820$31.56$720.2K903,115Oct 21, 2021Oct 22, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
11,565$31.02$358.8K925,935Oct 20, 2021Oct 22, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
4,549$27.28$124.1K937,500Sep 30, 2021Oct 1, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
7,836$26.69$209.2K942,049Sep 30, 2021Oct 1, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
8,365$29.06$243.1K950,585Sep 29, 2021Oct 1, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
700$30.06$21.0K949,885Sep 29, 2021Oct 1, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
7,806$27.99$218.5K958,950Sep 29, 2021Oct 1, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
100$32.00$3.2K966,756Sep 28, 2021Sep 29, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
13,812$30.52$421.5K966,856Sep 28, 2021Sep 29, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
13,075$32.59$426.1K986,925Sep 27, 2021Sep 29, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
100$34.19$3.4K980,668Sep 27, 2021Sep 29, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
6,157$33.51$206.3K980,768Sep 27, 2021Sep 29, 2021
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500May 17, 2021May 19, 2021
QURE
UNIQURE N.V.
SALEGRANT
Stock grant
2,06346,978Feb 27, 2020Mar 2, 2020
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
3,6203,620Feb 27, 2020Mar 2, 2020
QURE
UNIQURE N.V.
SALE
806$62.27$50.2K44,915Jan 28, 2020Jan 30, 2020
Other insiders · FDMT
Loading peer insiders…
About this filer
CIK 0001692929
ROLE
Director
PRIMARY
FDMT
COMPANIES
2
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001692929DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback